{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:25:50Z","timestamp":1777861550856,"version":"3.51.4"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Macular Telangiectasia type 1 is a congenital vascular disorder primarily affecting males, characterized by unilateral exudative lesions on the temporal macula. Intravitreal anti-VEGF therapy is commonly used, but the response can be suboptimal in some patients. In this case, we report the management of Macular Telangiectasia type 1 using a integration of intravitreal anti-VEGF therapy and traditional Chinese acupuncture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 38-year-old male presented with progressive vision loss and metamorphopsia in his right eye. Fundus examination and multimodal imaging (OCT\/OCTA and fluorescein angiography) identified a perimacular hard exudate ring, cystoid macular edema, and juxtafoveal telangiectasis, consistent with idiopathic Macular Telangiectasia type 1. For the intervention, the patient received a total of three intravitreal Conbercept injections administered once monthly, integrated with peri-treatment acupuncture at predefined acupoints. Four months after the last treatment, the patient exhibited both visual and anatomical improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The integration of traditional Chinese acupuncture with Conbercept may offer therapeutic benefits for Macular Telangiectasia type 1 in this patient. Clinically meaningful improvements were observed, including improved visual acuity, reduced metamorphopsia, and decreased central retinal thickness over follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1717145","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:25:50Z","timestamp":1777523150000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Macular Telangiectasia type 1 treated with integrated traditional Chinese acupuncture and Conbercept: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhifei","family":"Liu","sequence":"first","affiliation":[{"name":"Department of ENT, Ophthalmology and Oral Medicine, Chinese PLA 76th Army Corps Hospital","place":["Xining, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conghui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Air Force Hospital of Western Theater Command, PLA","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyue","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Air Force Hospital of Western Theater Command, PLA","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Air Force Hospital of Western Theater Command, PLA","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Air Force Hospital of Western Theater Command, PLA","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieqiong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Air Force Hospital of Western Theater Command, PLA","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"5395069","DOI":"10.1155\/2017\/5395069","article-title":"Unusual presentation of type 1 idiopathic Macular Telangiectasia","volume":"2017","author":"Za\u00efnab","year":"2017","journal-title":"Case Rep Ophthalmol Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/archopht.1982.01030030773010","article-title":"Idiopathic juxtafoveolar retinal telangiectasis","volume":"100","author":"Gass","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00417-020-04953-9","article-title":"Visualization of microaneurysms in Macular Telangiectasia type 1 on optical coherence tomography angiography before and after photocoagulation","volume":"259","author":"Mitsuko","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajo.2016.04.005","article-title":"Macular telangiectasia type 1: capillary density and microvascular abnormalities assessed by optical coherence tomography angiography","volume":"167","author":"Alexandre","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10103-018-2587-5","article-title":"Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of Macular Telangiectasia type 2 with retinal arterial macroaneurysm","volume":"34","author":"Demir","year":"2019","journal-title":"Lasers Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/jop.2015.0146","article-title":"Dexamethasone implant for the treatment of type 1 idiopathic Macular Telangiectasia","volume":"32","author":"G\u00fcrkan","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000369124","article-title":"Type 1 idiopathic Macular Telangiectasia associated with type 3 neovascularization","volume":"5","author":"Julien","year":"2015","journal-title":"Case Rep Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3341\/kjo.2019.0071","article-title":"Subthreshold micropulse yellow laser (577 nm) for idiopathic Macular Telangiectasia type 1 resistant to intravitreal injection","volume":"34","author":"Yong Koo","year":"2020","journal-title":"Korean J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1097\/IAE.0000000000001424","article-title":"Efficacy of intravitreal aflibercept in Macular Telangiectasia type 1 is linked to the ocular angiogenic profile","volume":"37","author":"Kowalczuk","year":"2017","journal-title":"Retina"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"00789-9","DOI":"10.1016\/j.ophtha.2024.12.025","article-title":"Retinal vein occlusions preferred practice pattern\u00ae","author":"Kovach","year":"2025","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ajo.2018.08.026","article-title":"Conbercept for treatment of neovascular age-related macular degeneration: results of the randomized phase 3 PHOENIX study","volume":"197","author":"Liu","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e067475","DOI":"10.1136\/bmj-2021-067475","article-title":"Evidence on acupuncture therapies is underused in clinical practice and health policy","volume":"376","author":"Lu","year":"2022","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1745-6215-15-130","article-title":"Acupuncture at local and distal points for chronic shoulder pain: study protocol for a randomized controlled trial","volume":"15","author":"Fu","year":"2014","journal-title":"Trials"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0254-6272(13)60162-4","article-title":"Mechanisms of qi-blood circulation and qi deficiency syndrome in view of blood and interstitial fluid circulation","volume":"33","author":"Yao","year":"2013","journal-title":"J Tradit Chin Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ecam\/nep006","article-title":"WHO standard acupuncture point locations","volume":"7","author":"Sabina","year":"2010","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"157090","DOI":"10.1155\/2011\/157090","article-title":"Short-term effects of acupuncture on open-angle glaucoma in retrobulbar circulation: additional therapy to standard medication","volume":"2011","author":"Seki","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1057929","DOI":"10.3389\/fnana.2022.1057929","article-title":"Electroacupuncture ameliorates inflammatory response induced by retinal ischemia-reperfusion injury and protects the retina through the DOR-BDNF\/TRKB pathway","volume":"16","author":"Guo","year":"2022","journal-title":"Front Neuroanat"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e2912","DOI":"10.1002\/brb3.2912","article-title":"Electroacupuncture reverses endothelial cell death and promotes angiogenesis through the VEGF\/notch signaling pathway after focal cerebral ischemia-reperfusion injury","volume":"13","author":"Zhang","year":"2023","journal-title":"Brain Behav"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1717145\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:25:53Z","timestamp":1777523153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1717145\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":18,"alternative-id":["10.3389\/fmed.2026.1717145"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1717145","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"1717145"}}